614 related articles for article (PubMed ID: 30052747)
21. Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study.
Tanner RM; Calhoun DA; Bell EK; Bowling CB; Gutiérrez OM; Irvin MR; Lackland DT; Oparil S; McClellan W; Warnock DG; Muntner P
Am J Kidney Dis; 2014 May; 63(5):781-8. PubMed ID: 24388119
[TBL] [Abstract][Full Text] [Related]
22. Prescription pattern of antihypertensive medications and blood pressure control among hypertensive outpatients at the University of Benin Teaching Hospital in Benin City, Nigeria.
Adejumo O; Okaka E; Iyawe I
Malawi Med J; 2017 Jun; 29(2):113-117. PubMed ID: 28955417
[TBL] [Abstract][Full Text] [Related]
23. Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy.
Benner JS; Chapman RH; Petrilla AA; Tang SS; Rosenberg N; Schwartz JS
Am J Health Syst Pharm; 2009 Aug; 66(16):1471-7. PubMed ID: 19667004
[TBL] [Abstract][Full Text] [Related]
24. Use of Pharmacy Sales Data to Assess Changes in Prescription- and Payment-Related Factors that Promote Adherence to Medications Commonly Used to Treat Hypertension, 2009 and 2014.
Ritchey M; Tsipas S; Loustalot F; Wozniak G
PLoS One; 2016; 11(7):e0159366. PubMed ID: 27428008
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of high-risk cardiovascular conditions and the status of hypertension management among hypertensive adults 65 years and older in the United States: analysis of a primary care electronic medical records database.
Biskupiak JE; Kim J; Phatak H; Wu D
J Clin Hypertens (Greenwich); 2010 Dec; 12(12):935-44. PubMed ID: 21122059
[TBL] [Abstract][Full Text] [Related]
26. Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease.
Ho PM; Magid DJ; Shetterly SM; Olson KL; Peterson PN; Masoudi FA; Rumsfeld JS
Arch Intern Med; 2008 Feb; 168(3):271-6. PubMed ID: 18268167
[TBL] [Abstract][Full Text] [Related]
27. NSAID-antihypertensive drug interactions: which outpatients are at risk for a rise in systolic blood pressure?
Floor-Schreudering A; De Smet PA; Buurma H; Kramers C; Tromp PC; Belitser SV; Bouvy ML
Eur J Prev Cardiol; 2015 Jan; 22(1):91-9. PubMed ID: 24042856
[TBL] [Abstract][Full Text] [Related]
28. The natural history of hypertension in older adults: a study of two Finnish generational cohorts born 20 years apart.
Lääti A; Teppo K; Vire J; Viitanen M; Langén V
Blood Press; 2024 Dec; 33(1):2368798. PubMed ID: 38912874
[TBL] [Abstract][Full Text] [Related]
29. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
Petrella R; Michailidis P
Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
[TBL] [Abstract][Full Text] [Related]
30. The impact of combinations of non-steroidal anti-inflammatory drugs and anti-hypertensive agents on blood pressure.
Kalafutova S; Juraskova B; Vlcek J
Adv Clin Exp Med; 2014; 23(6):993-1000. PubMed ID: 25618128
[TBL] [Abstract][Full Text] [Related]
31. Association Between Self-Reported Hypertension and Antihypertensive Medication Use and Cardiovascular Disease-Related Events and Expenditures Among Patients Diagnosed With Hypertension.
Baker-Goering MM; Howard DH; Will JC; Beeler Asay GR; Roy K
Public Health Rep; 2019; 134(5):493-501. PubMed ID: 31404507
[TBL] [Abstract][Full Text] [Related]
32. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.
Filippi A; Paolini I; Innocenti F; Mazzaglia G; Battaggia A; Brignoli O
J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492
[TBL] [Abstract][Full Text] [Related]
33. Use of nonsteroidal anti-inflammatory drugs and gastroprotective agents before the advent of cyclooxygenase-2-selective inhibitors: analysis of a large United States claims database.
Schnitzer TJ; Kong SX; Mavros PP; Straus WL; Watson DJ
Clin Ther; 2001 Dec; 23(12):1984-98. PubMed ID: 11813933
[TBL] [Abstract][Full Text] [Related]
34. Treatment Resistant Hypertension.
Egan BM
Ethn Dis; 2015 Nov; 25(4):495-8. PubMed ID: 26674466
[TBL] [Abstract][Full Text] [Related]
35. Incidence, prevalence, and predictors of treatment-resistant hypertension with intensive blood pressure lowering.
Smith SM; Gurka MJ; Winterstein AG; Pepine CJ; Cooper-DeHoff RM
J Clin Hypertens (Greenwich); 2019 Jun; 21(6):825-834. PubMed ID: 31066177
[TBL] [Abstract][Full Text] [Related]
36. Predictors of first-fill adherence for patients with hypertension.
Shah NR; Hirsch AG; Zacker C; Wood GC; Schoenthaler A; Ogedegbe G; Stewart WF
Am J Hypertens; 2009 Apr; 22(4):392-6. PubMed ID: 19180061
[TBL] [Abstract][Full Text] [Related]
37. Resistant hypertension revisited: a comparison of two university-based cohorts.
Garg JP; Elliott WJ; Folker A; Izhar M; Black HR;
Am J Hypertens; 2005 May; 18(5 Pt 1):619-26. PubMed ID: 15882544
[TBL] [Abstract][Full Text] [Related]
38. Trends in Antihypertensive Medication Monotherapy and Combination Use Among US Adults, National Health and Nutrition Examination Survey 2005-2016.
Derington CG; King JB; Herrick JS; Shimbo D; Kronish IM; Saseen JJ; Muntner P; Moran AE; Bress AP
Hypertension; 2020 Apr; 75(4):973-981. PubMed ID: 32148129
[TBL] [Abstract][Full Text] [Related]
39. Quality of hypertension pharmacotherapy in Quebec: a population-based study.
Tremblay É; Turgeon M; Gaudet M; Guénette L
J Popul Ther Clin Pharmacol; 2014; 21(3):e431-41. PubMed ID: 25527799
[TBL] [Abstract][Full Text] [Related]
40. Management Practices in Indian Patients with Uncontrolled Hypertension.
Bharatia R; Chitale M; Saxena GN; Kumar RG; Chikkalingaiah ; Trailokya A; Dalvi K; Talele S
J Assoc Physicians India; 2016 Jul; 64(7):14-21. PubMed ID: 27759337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
